Endocrinology status update: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 431: Line 431:
|-
|-
|}
|}
==Completed chapters==
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters that need content}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Coach name}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Completion Status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Review status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Reviewer name}}
|-
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Obstetrics
| style="padding: 5px 5px; background: #F5F5F5;" |Diabetes Landing Page
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Diabetes Type I
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Diabetes Type II
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |GDM
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Diabetes insipidus
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Pituitary disorders landing page
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypopituitarism
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Sheehan Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypogonadism
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |GH deficiency
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Prolactinoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Acromegaly
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Pituitary apoplexy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Thyroid disorders landing page
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hyperthyroidism landing page
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Graves Disease
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Toxic Multinodular goiter
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Goiter
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Toxic adenoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Struma ovarii
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypothyroidism landing page
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|Primary hypothyroidism (hypothyroidism)
|
|
|
|
|
|
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Hashimoto thyroiditis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|
|
|
|
|
|
|
|-
|}
==Completed chapters==
==Completed chapters==


Line 670: Line 445:
|-
|-
| rowspan="88" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |CVS
| rowspan="88" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |CVS
| style="padding: 5px 5px; background: #F5F5F5;" |[[Abdominal aortic aneurysm|Diabetes Landing Page]]
| style="padding: 5px 5px; background: #F5F5F5;" |Diabetes Landing Page
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar
Line 678: Line 453:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Acute coronary syndromes|Diabetes Type I]]
| style="padding: 5px 5px; background: #F5F5F5;" |Diabetes Type I
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon
| style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon
Line 686: Line 461:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Acute aortic syndrome|Diabetes Type II]]
| style="padding: 5px 5px; background: #F5F5F5;" |Diabetes Type II
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sahar
| style="padding: 5px 5px; background: #F5F5F5;" |Sahar
Line 726: Line 501:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Atrial fibrillation|Sheehan Syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Hasan
| style="padding: 5px 5px; background: #F5F5F5;" |Hasan
Line 734: Line 509:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Atrial septal defect]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ifeoma
| style="padding: 5px 5px; background: #F5F5F5;" |Ifeoma
Line 742: Line 517:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Beriberi|Beri Beri]]
| style="padding: 5px 5px; background: #F5F5F5;" |Beri Beri
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
Line 750: Line 525:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Sheehan Syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Shadi Ebr
| style="padding: 5px 5px; background: #F5F5F5;" |Shadi Ebr
Line 758: Line 533:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Blalock-Taussig shunt|Hypogonadism]]
| style="padding: 5px 5px; background: #F5F5F5;" |Hypogonadism
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Usman Ali Akbar
| style="padding: 5px 5px; background: #F5F5F5;" |Usman Ali Akbar
Line 766: Line 541:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Brugada syndrome|GH deficiency]]
| style="padding: 5px 5px; background: #F5F5F5;" |GH deficiency
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
Line 774: Line 549:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Bundle branch block|Prolactinoma]]
| style="padding: 5px 5px; background: #F5F5F5;" |Prolactinoma
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Maneesha
| style="padding: 5px 5px; background: #F5F5F5;" |Maneesha
Line 782: Line 557:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac amyloidosis|Acromegaly]]
| style="padding: 5px 5px; background: #F5F5F5;" |Acromegaly
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon
| style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon
Line 790: Line 565:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac tamponade|Pituitary apoplexy]]
| style="padding: 5px 5px; background: #F5F5F5;" |Pituitary apoplexy
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar
Line 798: Line 573:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac fibrosis|Thyroid disorders landing page]]
| style="padding: 5px 5px; background: #F5F5F5;" |Thyroid disorders landing page
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Niloofar
| style="padding: 5px 5px; background: #F5F5F5;" |Niloofar
Line 806: Line 581:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiogenic shock|Hyperthyroidism landing page]]
| style="padding: 5px 5px; background: #F5F5F5;" |Hyperthyroidism landing page
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ali
| style="padding: 5px 5px; background: #F5F5F5;" |Ali
Line 814: Line 589:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cardiac transplantation|Graves Disease]]
| style="padding: 5px 5px; background: #F5F5F5;" |Graves Disease
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ifrah Fatima
| style="padding: 5px 5px; background: #F5F5F5;" |Ifrah Fatima
Line 822: Line 597:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Chagas disease|Goiter]]
| style="padding: 5px 5px; background: #F5F5F5;" |Goiter
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
Line 830: Line 605:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Congenital heart block|Toxic Multinodular goiter]]
| style="padding: 5px 5px; background: #F5F5F5;" |Toxic Multinodular goiter
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
Line 838: Line 613:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Constrictive pericarditis|Toxic adenoma]]
| style="padding: 5px 5px; background: #F5F5F5;" |Toxic adenoma
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
Line 846: Line 621:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Cyanotic heart disease|Struma ovarii]]
| style="padding: 5px 5px; background: #F5F5F5;" |Struma ovarii
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime
Line 854: Line 629:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Dressler's syndrome|Hypothyroidism landing page]]
| style="padding: 5px 5px; background: #F5F5F5;" |Hypothyroidism landing page
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
Line 862: Line 637:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Ebstein's anomaly|Primary hypothyroidism (hypothyroidism)]]
| style="padding: 5px 5px; background: #F5F5F5;" |Primary hypothyroidism (hypothyroidism)
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Maneesha
| style="padding: 5px 5px; background: #F5F5F5;" |Maneesha
Line 870: Line 645:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Eisenmenger's syndrome|Hashimoto thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |Hashimoto thyroiditis
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
Line 886: Line 661:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Endocarditis|Secondary hypothyroidism]]
| style="padding: 5px 5px; background: #F5F5F5;" |Secondary hypothyroidism
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime
Line 894: Line 669:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Dilated cardiomyopathy|Thyroiditis Landing page]]
| style="padding: 5px 5px; background: #F5F5F5;" |Thyroiditis Landing page
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
Line 902: Line 677:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[First degree AV block|Hashimotos  Thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |Hashimotos  Thyroiditis
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed
Line 910: Line 685:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Congestive heart failure|Dequervian  Thyroiditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |Dequervian  Thyroiditis
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Hasan
| style="padding: 5px 5px; background: #F5F5F5;" |Hasan
Line 918: Line 693:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Heart in Kawasaki disease]]
| style="padding: 5px 5px; background: #F5F5F5;" |Riedel's Thyroiditis
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon
| style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon
Line 926: Line 701:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[HIV induced pericarditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |Silent Thyroiditis
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar
Line 934: Line 709:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Holiday heart syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |Postpartum Thyroiditis
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Apeksha Gupta
| style="padding: 5px 5px; background: #F5F5F5;" |Apeksha Gupta
Line 942: Line 717:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Hypertrophic obstructive cardiomyopathy]]
| style="padding: 5px 5px; background: #F5F5F5;" |Thyroid nodule
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Soroush
| style="padding: 5px 5px; background: #F5F5F5;" |Soroush
Line 950: Line 725:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Kawasaki disease]]
| style="padding: 5px 5px; background: #F5F5F5;" |Sick euthyroid syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime
Line 958: Line 733:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Jervell and Lange-Nielsen syndrome|Jervel Lange Nielson Syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |Thyroid carcinoma landing page
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
Line 966: Line 741:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Libman-Sacks endocarditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |Myxedama coma
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sara
| style="padding: 5px 5px; background: #F5F5F5;" |Sara
Line 974: Line 749:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Long QT syndrome|Long QT syndrome (LQTS)]]
| style="padding: 5px 5px; background: #F5F5F5;" |Postpartum thyroid dysfunction L.
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
Line 982: Line 757:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Loeffler endocarditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |Adrenal disorders landing page
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Soroush
| style="padding: 5px 5px; background: #F5F5F5;" |Soroush
Line 990: Line 765:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Mitral stenosis]]
| style="padding: 5px 5px; background: #F5F5F5;" |Adrenal insufficiency landing page
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
Line 998: Line 773:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Myocardial abscess]]
| style="padding: 5px 5px; background: #F5F5F5;" |Adrenocortical carcinoma
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ali
| style="padding: 5px 5px; background: #F5F5F5;" |Ali
Line 1,006: Line 781:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Myocarditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |CAH L
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Homa
| style="padding: 5px 5px; background: #F5F5F5;" |Homa
Line 1,014: Line 789:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Myxoma]]
| style="padding: 5px 5px; background: #F5F5F5;" |21 hydroxylase def
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
Line 1,022: Line 797:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Myxomatous degeneration]]
| style="padding: 5px 5px; background: #F5F5F5;" |11 hydroxylase def
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 1,030: Line 805:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Nonbacterial thrombotic endocarditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |17 hydroxylase def
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Homa
| style="padding: 5px 5px; background: #F5F5F5;" |Homa
Line 1,038: Line 813:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Obesity cardiomyopathy]]
| style="padding: 5px 5px; background: #F5F5F5;" |Addisons disease
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Soroush
| style="padding: 5px 5px; background: #F5F5F5;" |Soroush
Line 1,046: Line 821:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Paget-Schroetter disease]]
| style="padding: 5px 5px; background: #F5F5F5;" |Incidentiloma
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Anahita Deylamshahi
| style="padding: 5px 5px; background: #F5F5F5;" |Anahita Deylamshahi
Line 1,054: Line 829:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Parasystole]]
| style="padding: 5px 5px; background: #F5F5F5;" |Pheochromocytoma
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Mohammed Salih
| style="padding: 5px 5px; background: #F5F5F5;" |Mohammed Salih
Line 1,062: Line 837:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Paroxysmal AV block]]
| style="padding: 5px 5px; background: #F5F5F5;" |P hyperaldosteronism(Conn's)
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Akash Daswaney
| style="padding: 5px 5px; background: #F5F5F5;" |Akash Daswaney
Line 1,070: Line 845:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Patent ductus arteriosus]]
| style="padding: 5px 5px; background: #F5F5F5;" |Hypoaldosteronism
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar
| style="padding: 5px 5px; background: #F5F5F5;" |Ramyar
Line 1,078: Line 853:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Patent foramen ovale]]
| style="padding: 5px 5px; background: #F5F5F5;" |Cushing's syndrome/Pseudo-Cushing's syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ifoma
| style="padding: 5px 5px; background: #F5F5F5;" |Ifoma
Line 1,086: Line 861:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Penetrating atherosclerotic aortic ulcer]]
| style="padding: 5px 5px; background: #F5F5F5;" |Secondary Adrenal Insufficiency
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sahar
| style="padding: 5px 5px; background: #F5F5F5;" |Sahar
Line 1,094: Line 869:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Pentalogy of Fallot]]
| style="padding: 5px 5px; background: #F5F5F5;" |'''MEN type I'''
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Abdulkareem Lukan
| style="padding: 5px 5px; background: #F5F5F5;" |Abdulkareem Lukan
Line 1,102: Line 877:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Pericardial effusion]]
| style="padding: 5px 5px; background: #F5F5F5;" |MEN type 2
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
Line 1,110: Line 885:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Post-cardiac injury syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |Protein energy maln. (Kwashiorkor, Marasmus)
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ibtisam Ashraf
| style="padding: 5px 5px; background: #F5F5F5;" |Ibtisam Ashraf
Line 1,118: Line 893:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Post myocardial infarction pericarditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |Metabolic syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Mandana
| style="padding: 5px 5px; background: #F5F5F5;" |Mandana
Line 1,126: Line 901:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Postpericardiotomy syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |Hypoglycemia
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Niloofar
| style="padding: 5px 5px; background: #F5F5F5;" |Niloofar
Line 1,134: Line 909:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Pericarditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |Glucaganoma
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Homa
| style="padding: 5px 5px; background: #F5F5F5;" |Homa
Line 1,142: Line 917:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Pre-excitation syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |Insulinoma (hyperinsulism, hyperinsulinemia)
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Shivam
| style="padding: 5px 5px; background: #F5F5F5;" |Shivam
Line 1,150: Line 925:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Premature atrial contraction]]
| style="padding: 5px 5px; background: #F5F5F5;" |DKA
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
Line 1,158: Line 933:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Prinzmetal's angina]]
| style="padding: 5px 5px; background: #F5F5F5;" |HONK/HHS
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
Line 1,166: Line 941:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Restrictive cardiomyopathy|Restrictive Cardiomyopathy]]
| style="padding: 5px 5px; background: #F5F5F5;" |Androgen insensitivity
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Maneesha
| style="padding: 5px 5px; background: #F5F5F5;" |Maneesha
Line 1,174: Line 949:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Rheumatic heart disease]]
| style="padding: 5px 5px; background: #F5F5F5;" |Gynecomastia
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
Line 1,182: Line 957:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[2nd degree heart block]]
| style="padding: 5px 5px; background: #F5F5F5;" |Hirsutism
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed
Line 1,190: Line 965:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Sick sinus syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |Polycystic Ovarian Disease
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sahar
| style="padding: 5px 5px; background: #F5F5F5;" |Sahar
Line 1,198: Line 973:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Supraventricular tachycardia]]
| style="padding: 5px 5px; background: #F5F5F5;" |Delayed puberty
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
| style="padding: 5px 5px; background: #F5F5F5;" |Abdelrahman
Line 1,206: Line 981:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Tetralogy of Fallot]]
| style="padding: 5px 5px; background: #F5F5F5;" |Parathyroid disorders LP
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime
Line 1,214: Line 989:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Third degree AV block]]
| style="padding: 5px 5px; background: #F5F5F5;" |Hypoparathyroidism
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Qasim Khurshid
| style="padding: 5px 5px; background: #F5F5F5;" |Qasim Khurshid
Line 1,222: Line 997:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Transesophageal echocardiography (TEE)|Transesophageal echocardiography]]
| style="padding: 5px 5px; background: #F5F5F5;" |Pseudohypoparathyroidism
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba Hassanzadeh
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba Hassanzadeh
Line 1,230: Line 1,005:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Transposition of the great vessels|Transposition of great arteries]]
| style="padding: 5px 5px; background: #F5F5F5;" |Hyperparathyroidism
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
Line 1,238: Line 1,013:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Tricuspid atresia]]
| style="padding: 5px 5px; background: #F5F5F5;" |Familial hypocalciuric hypercalcemia
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sara Zand
| style="padding: 5px 5px; background: #F5F5F5;" |Sara Zand
Line 1,246: Line 1,021:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Tricuspid regurgitation]]
| style="padding: 5px 5px; background: #F5F5F5;" |Osteoporosis
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
Line 1,254: Line 1,029:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Timothys syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |Zollinger-Ellison syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
Line 1,262: Line 1,037:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Tuberculous pericarditis]]
| style="padding: 5px 5px; background: #F5F5F5;" |Syndrome of inappropriate antidiuretic hormone
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime
| style="padding: 5px 5px; background: #F5F5F5;" |Fahime
Line 1,270: Line 1,045:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Ventricular septal defect]]
| style="padding: 5px 5px; background: #F5F5F5;" |Autoimmune polyendocrine syndromes
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
Line 1,278: Line 1,053:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Ventricular fibrillation]]
| style="padding: 5px 5px; background: #F5F5F5;" |Amenorrhea
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Sahar
| style="padding: 5px 5px; background: #F5F5F5;" |Sahar
Line 1,286: Line 1,061:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Long QT syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Complete
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |In progress
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Angina pectoris]]
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Complete
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |In progress
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Mitral regurgitation]]
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Complete
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |In progress
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Pulmonic regurgitation|Pulmonary valve regurgitation]]
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Complete
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |In progress
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Preoperative cardiac risk assessment]]
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Complete
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |In progress
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |[[Percutaneous coronary intervention]]
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Complete
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |In progress
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|}
|}

Revision as of 03:14, 22 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.

System leader: Sogand Goudarzi, M.D.

Progress
Completed
In progress
Remaining

List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Endocrinology Pheochromocytoma Assigned Ifrah Sogand In Progress
Metabolic syndrome X Assigned Mina Sogand In Progress
Gestentional Diabetes
Disbetes Insipidus Assigned Anahita Krishna In Progress
Hypopitutarism
Sheenhan's Syndrome
Hypogonadism
GH deficiency
Primary hyperaldostronism


In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Endocrinology Metabolic syndrome X Assigned Fatemeh Dehghani Fiouzabadi Sogand In progress Sogand
DM Type I Assigned Sogand In progress
Disbetes Insipidus Assigned Anahita Krishna In progress

Completed chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
CVS Diabetes Landing Page Assigned Ramyar Complete In progress
Diabetes Type I Assigned Sabawoon Complete In progress
Diabetes Type II Assigned Sahar Complete In progress
Diabetes insipidus Assigned Sahar Complete In progress
Pituitary disorders landing page Assigned Cafer Zorkon Complete In progress
Hypopituitarism Assigned Mandana Complete In progress
Sheehan Syndrome Assigned Javaria Anwer Farima Complete In progress
Assigned Hasan Complete In progress
Assigned Ifeoma Complete In progress
Beri Beri Assigned Abdelrahman Complete In progress
Assigned Shadi Ebr Sahar Complete In progress
Hypogonadism Assigned Usman Ali Akbar Sara Complete In progress
GH deficiency Assigned Sogand Complete In progress
Prolactinoma Assigned Maneesha Complete In progress
Acromegaly Assigned Sabawoon Complete In progress
Pituitary apoplexy Assigned Ramyar Complete In progress
Thyroid disorders landing page Assigned Niloofar Complete In progress
Hyperthyroidism landing page Assigned Ali Complete In progress
Graves Disease Assigned Ifrah Fatima Sogand Complete In progress
Goiter Assigned Huda Complete In progress
Toxic Multinodular goiter Assigned Sogand Complete In progress
Toxic adenoma Assigned Huda Complete In progress
Struma ovarii Assigned Fahime Complete In progress
Hypothyroidism landing page Assigned Abdelrahman Complete In progress
Primary hypothyroidism (hypothyroidism) Assigned Maneesha Complete In progress
Hashimoto thyroiditis Assigned Abdelrahman Complete In progress
Congenital hypothyroidism/Cretinism Assigned Aditya Complete In progress
Secondary hypothyroidism Assigned Fahime Complete In progress
Thyroiditis Landing page Assigned Abdelrahman Complete In progress
Hashimotos Thyroiditis Assigned Ahmed Complete In progress
Dequervian Thyroiditis Assigned Hasan Complete In progress
Riedel's Thyroiditis Assigned Sabawoon Complete In progress
Silent Thyroiditis Assigned Ramyar Complete In progress
Postpartum Thyroiditis Assigned Apeksha Gupta Aditya Complete In progress
Thyroid nodule Assigned Soroush Complete In progress
Sick euthyroid syndrome Assigned Fahime Complete In progress
Thyroid carcinoma landing page Assigned Krishna Complete In progress
Myxedama coma Assigned Sara Complete In progress
Postpartum thyroid dysfunction L. Assigned Krishna Complete In progress
Adrenal disorders landing page Assigned Soroush Complete In progress
Adrenal insufficiency landing page Assigned Aditya Complete In progress
Adrenocortical carcinoma Assigned Ali Complete In progress
CAH L Assigned Homa Complete In progress
21 hydroxylase def Assigned Sogand Complete In progress
11 hydroxylase def Assigned Ali Complete In progress
17 hydroxylase def Assigned Homa Complete In progress
Addisons disease Assigned Soroush Complete In progress
Incidentiloma Assigned Anahita Deylamshahi Krishna Complete In progress
Pheochromocytoma Assigned Mohammed Salih Complete In progress
P hyperaldosteronism(Conn's) Assigned Akash Daswaney Homa Complete In progress
Hypoaldosteronism Assigned Ramyar Complete In progress
Cushing's syndrome/Pseudo-Cushing's syndrome Assigned Ifoma Complete In progress
Secondary Adrenal Insufficiency Assigned Sahar Complete In progress
MEN type I Assigned Abdulkareem Lukan Sahar Complete In progress
MEN type 2 Assigned Abdelrahman Complete In progress
Protein energy maln. (Kwashiorkor, Marasmus) Assigned Ibtisam Ashraf Sahar Complete In progress
Metabolic syndrome Assigned Mandana Complete In progress
Hypoglycemia Assigned Niloofar Complete In progress
Glucaganoma Assigned Homa Complete In progress
Insulinoma (hyperinsulism, hyperinsulinemia) Assigned Shivam Sara Complete In progress
DKA Assigned Amandeep Complete In progress
HONK/HHS Assigned Amandeep Complete In progress
Androgen insensitivity Assigned Maneesha Complete In progress
Gynecomastia Assigned Huda Complete In progress
Hirsutism Assigned Ahmed Complete In progress
Polycystic Ovarian Disease Assigned Sahar Complete In progress
Delayed puberty Assigned Abdelrahman Complete In progress
Parathyroid disorders LP Assigned Fahime Complete In progress
Hypoparathyroidism Assigned Qasim Khurshid Maneesha Complete In progress
Pseudohypoparathyroidism Assigned Shakiba Hassanzadeh Ahmed Complete In progress
Hyperparathyroidism Assigned Aditya Complete In progress
Familial hypocalciuric hypercalcemia Assigned Sara Zand Fahime Complete In progress
Osteoporosis Assigned Krishna Complete In progress
Zollinger-Ellison syndrome Assigned Krishna Complete In progress
Syndrome of inappropriate antidiuretic hormone Assigned Fahime Complete In progress
Autoimmune polyendocrine syndromes Assigned Huda Complete In progress
Amenorrhea Assigned Sahar Complete In progress
Retrieved from "https://www.wikidoc.org/index.php?title=Endocrinology_status_update&oldid=1630739"